Xiaowen Tang

5.3k total citations · 2 hit papers
238 papers, 3.1k citations indexed

About

Xiaowen Tang is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Xiaowen Tang has authored 238 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 130 papers in Hematology, 64 papers in Oncology and 63 papers in Molecular Biology. Recurrent topics in Xiaowen Tang's work include Acute Myeloid Leukemia Research (74 papers), Hematopoietic Stem Cell Transplantation (68 papers) and Acute Lymphoblastic Leukemia research (41 papers). Xiaowen Tang is often cited by papers focused on Acute Myeloid Leukemia Research (74 papers), Hematopoietic Stem Cell Transplantation (68 papers) and Acute Lymphoblastic Leukemia research (41 papers). Xiaowen Tang collaborates with scholars based in China, United States and Canada. Xiaowen Tang's co-authors include Depei Wu, Depei Wu, Haiping Dai, Zhengtao Wang, Li Yang, Xiaming Zhu, Qiaoling Yang, Huiying Qiu, Lin Yang and Yue Han and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Xiaowen Tang

219 papers receiving 3.0k citations

Hit Papers

Erratum: First-in-man cli... 2018 2026 2020 2023 2018 2021 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia.
    2018 356 citations Xiaowen Tang, Lin Yang et al. PubMed profile →
  2. The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update
    2021 150 citations Xiaowen Tang, Depei Wu et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Xiaowen Tang 1.2k 1.0k 943 724 355 238 3.1k
Yuanyuan Zhang 927 0.7× 342 0.3× 848 0.9× 418 0.6× 163 0.5× 102 2.4k
Bing Xu 1.5k 1.2× 693 0.7× 386 0.4× 452 0.6× 119 0.3× 192 3.1k
Carlo Rumi 693 0.6× 430 0.4× 539 0.6× 682 0.9× 145 0.4× 103 2.3k
Jingsong He 1.0k 0.8× 865 0.8× 572 0.6× 452 0.6× 131 0.4× 136 2.5k
Pankaj Gupta 617 0.5× 460 0.4× 313 0.3× 1000 1.4× 82 0.2× 75 2.6k
James O’Kelly 1.4k 1.2× 477 0.5× 337 0.4× 345 0.5× 64 0.2× 59 3.0k
Hua Jiang 1.4k 1.1× 620 0.6× 273 0.3× 460 0.6× 124 0.3× 125 2.5k
Eliana Abdelhay 1.1k 0.9× 474 0.5× 204 0.2× 244 0.3× 108 0.3× 125 2.0k
Ting Zhao 1.5k 1.2× 482 0.5× 316 0.3× 695 1.0× 132 0.4× 105 2.9k
Ting Li 767 0.6× 972 0.9× 196 0.2× 416 0.6× 89 0.3× 172 2.6k

Countries citing papers authored by Xiaowen Tang

Since Specialization
Citations

This map shows the geographic impact of Xiaowen Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowen Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowen Tang more than expected).

Fields of papers citing papers by Xiaowen Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowen Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowen Tang. The network helps show where Xiaowen Tang may publish in the future.

Co-authorship network of co-authors of Xiaowen Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowen Tang. A scholar is included among the top collaborators of Xiaowen Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowen Tang. Xiaowen Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yujie, Jiaqi Li, Ying Wang, et al.. (2025). Clinical Outcomes of CD7 CAR‐T Cell Therapy in Relapsed or Refractory T‐Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Patients. Hematological Oncology. 43(3). e70081–e70081. 2 indexed citations
2.
Zhang, Zhibo, Jia Yin, Jun Wang, et al.. (2025). Real-world Efficacy and Safety of Flumatinib as the First-line Treatment in Patients With de novo Philadelphia-positive Acute Lymphoblastic Leukemia. Clinical Lymphoma Myeloma & Leukemia. 25(10). e731–e739.e4.
3.
Tang, Xiaowen, Hongying Fu, Xiaobo Fan, et al.. (2025). Mechanistic insights into carbon black-activated AKT/TMEM175 cascade impairing macrophage-epithelial cross-talk and airway epithelial proliferation. Environmental Pollution. 372. 126076–126076.
4.
Yu, Xiaojuan, et al.. (2024). Comparative study of job burnout in Shanghai‐based nurses against Maslach norm and Hangzhou norm. International Nursing Review. 72(1). e12952–e12952. 1 indexed citations
5.
6.
Xu, Mingming, et al.. (2024). Network pharmacology-based investigation and experimental validation of the mechanism of metformin in the treatment of acute myeloid leukemia. European journal of medical research. 29(1). 475–475. 2 indexed citations
7.
8.
Cui, Wei, Ying Wang, Xiaowen Tang, et al.. (2024). CRM197-scaffolded vaccines designed by epitope grafting ameliorate cognitive decline in an Alzheimer's disease model. International Journal of Biological Macromolecules. 281(Pt 4). 136477–136477. 2 indexed citations
9.
Li, Yangzi, Sining Liu, Qingya Cui, et al.. (2023). Rituximab Improves Clinical Outcomes of CAR-T Therapy for r/r B-ALL Via Sensitizing Leukemia Cells to CAR-T-Mediated Cytotoxicity and Reducing CAR-T Exhaustion. Blood. 142(Supplement 1). 6803–6803. 5 indexed citations
10.
Wang, Hong, Qingyuan Wang, Jiaqian Qi, et al.. (2023). Appropriate pre-transplant strategy for patients with myelodysplastic syndromes receiving allogeneic haematopoietic stem cell transplantation after myeloablative conditioning. Frontiers in Immunology. 14. 1146619–1146619. 2 indexed citations
11.
12.
Gao, Yang, et al.. (2023). Patterns of distant metastases in patients with triple‐negative breast cancer—A population‐based study. SHILAP Revista de lepidopterología. 12(3). 182–195. 5 indexed citations
13.
Qi, Jiaqian, Yuanxin Zhu, Yang Xu, et al.. (2021). Impact of disease status at allogeneic stem cell transplantation on adolescent and young adult patients with early T‐cell precursor acute lymphoblastic leukemia. Hematological Oncology. 39(3). 358–363. 2 indexed citations
14.
Qi, Jiaqian, Xin Lv, Jia Chen, et al.. (2021). TNF‐α increases the risk of bleeding in patients after CAR T‐cell therapy: A bleeding model based on a real‐world study of Chinese CAR T Working Party. Hematological Oncology. 40(1). 64–72. 8 indexed citations
15.
Zhang, Jian, Xinyou Zhang, Lili Zhou, et al.. (2020). Donor-derived anti-CD19 CAR T cells compared with donor lymphocyte infusion for recurrent B-ALL after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 56(5). 1056–1064. 21 indexed citations
16.
Kang, Liqing, Xiaowen Tang, Nan Xu, et al.. (2019). shRNA-Interleukin-6 Modified CD19-Specific Chimeric Antigen Receptor T Cell Significantly Improves the Safety in Acute Lymphoblastic Leukemia. Blood. 134(Supplement_1). 2621–2621. 2 indexed citations
17.
Yang, Xiaofei, Shuo Yang, Aining Sun, et al.. (2018). Impact of cyclosporine‐A concentration in T‐cell replete haploidentical allogeneic stem cell transplantation. Clinical Transplantation. 32(4). e13220–e13220. 5 indexed citations
18.
19.
Xu, Ying, et al.. (2014). Analytical Methods for Characterization of Bile Acids and Its Application in Quality Control of Cow-Bezoar and Bear Bile Powder. American Journal of Applied Chemistry. 2(6). 96. 5 indexed citations
20.
Chen, Bobei, Dongmei Sun, Li Yang, et al.. (2008). Mitochondrial ND5 T12338C, tRNACys T5802C, and tRNAThr G15927A variants may have a modifying role in the phenotypic manifestation of deafness‐associated 12S rRNA A1555G mutation in three Han Chinese pedigrees. American Journal of Medical Genetics Part A. 146A(10). 1248–1258. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuanyuan Zhang Breakdown of academic impact, for papers by Bing Xu Breakdown of academic impact, for papers by Carlo Rumi Breakdown of academic impact, for papers by Jingsong He Breakdown of academic impact, for papers by Pankaj Gupta Breakdown of academic impact, for papers by James O’Kelly Breakdown of academic impact, for papers by Hua Jiang Breakdown of academic impact, for papers by Eliana Abdelhay Breakdown of academic impact, for papers by Ting Zhao Breakdown of academic impact, for papers by Ting Li
Rankless by CCL
2026